Coronavirus Vaccines (COVID-19; SARS-COV-2): preliminary review of articles, patents, clinical trials and marke

• Autor(a) principal: Quintella, Cristina M.
• Data de Publicação: 2020
• Outros Autores: Mata, Ana Maria Tavares da, Ghesti, Grace Ferreira, Mata, Pedro Miguel de Assis Lopes Tavares da
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Cadernos de Prospecção (Online)
• DOI: 10.9771/cp.v13i1.35871
• Texto Completo: https://periodicos.ufba.br/index.php/nit/article/view/35871
• topic: Pandemia; Imunização; Micro-organismos; Biotecnologia; Avaliação Tecnológica; Conhecimento Científico; COVID-19; Vacina; Coronavírus.; Pandemic; Immunization; Microorganisms; Technological Evaluation; Biotechnology; Scientific Knowledge; COVID-19; Vaccine; Corona Virus.

The recent Coronavirus outbreak has sparked a worldwide pandemic. This article consists of an exploratory study to assess the existing volume of material and the potential for further technological assessment and forecast. It is used to assess the knowledge that exists in science (through articles), in technology (through patents), in clinical tests and ready for use (through vaccines available on the market). The articles were mapped on the Web of Knowledge, the patent assessment used the European Worldwide database, using the Orbit® software. 991 patents, 125 articles and 115 clinical studies were found, with only 2 explicitly referring to vaccines. The annual evolution shows an exponential growth from 2002-2004 for articles and for patents. The vast majority of clinical studies have not yet started (only 15% have been completed), showing that there is an urgent need to stimulate their maturation. There is still no vaccine on the market that is considered worldwide effective.